PanGIA Biotech’s executive team brings together deep experience in science, strategy, and healthcare innovation.
With a shared commitment to accessibility and equity, they are pioneering non-invasive diagnostics that reimagine what’s possible in early cancer detection.
A pioneer in AI-driven diagnostics, Dr. Piloto leads scientific development at PanGIA Biotech. His expertise in biomolecular profiling underpins the company’s innovative approach to accurate, non-invasive cancer detection.